{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:20:29Z","timestamp":1789698029873,"version":"4.0.1"},"reference-count":45,"publisher":"The Endocrine Society","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The 1-mg overnight dexamethasone suppression test (1-mg DST) is widely used to screen for hypercortisolism, but its interpretation may be affected by variability in dexamethasone exposure due to clinical and pharmacological factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate determinants of serum dexamethasone levels during 1-mg DST and their impact on test interpretation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Observational study including 546 patients undergoing 1-mg DST with measurement of serum cortisol and dexamethasone levels. Clinical variables (age, body mass index [BMI], and estimated glomerular filtration rate [eGFR]) and concomitant medications were analyzed. Associations with dexamethasone levels were assessed using multivariable linear regression; suboptimal exposure (&amp;lt;4.5\u2005nmol\/L) was evaluated by logistic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median dexamethasone concentration was 11.9\u2005nmol\/L. In multivariable analysis, age (\u03b2 = .24, P &amp;lt; .001) and BMI (\u03b2 = .17, P = .010) were independently associated with higher dexamethasone levels, whereas eGFR was not. Concomitant medications (PPIs, statins, and calcium channel blockers) were associated with higher dexamethasone levels in univariable analyses, but not after sensitivity analyses. Age-stratified models showed that BMI and proton pump inhibitor use were associated with dexamethasone in patients &amp;lt;65 years, whereas statins and PPIs were determinants in those \u226565 years. Body mass index and eGFR remained significant after excluding patients with mild autonomous cortisol secretion. Suboptimal dexamethasone exposure occurred in 3.3% of patients and was frequently associated with inadequate cortisol suppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Age and BMI emerged as determinants of dexamethasone exposure during 1-mg DST, while the impact of renal function and medications appears limited after adjustment. Measuring dexamethasone may improve test interpretation; however, once adequate dexamethasone exposure is achieved, higher dexamethasone levels are not associated with additional cortisol suppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag370","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:52:49Z","timestamp":1788616369000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical and pharmacological determinants of serum dexamethasone concentrations during dexamethasone suppression test"],"prefix":"10.1210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4092-5107","authenticated-orcid":false,"given":"Irene","family":"Tizianel","sequence":"first","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]},{"name":"Endocrinology Unit, Padova University Hospital , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-5378","authenticated-orcid":false,"given":"Giorgia","family":"Antonelli","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]},{"name":"Laboratory Medicine Unit, Padova University Hospital , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6046-5198","authenticated-orcid":false,"given":"Alessandro","family":"Mondin","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]},{"name":"Endocrinology Unit, Padova University Hospital , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-4876","authenticated-orcid":false,"given":"Andrea","family":"Cignarella","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9899-9328","authenticated-orcid":false,"given":"Pierluigi","family":"Mazzeo","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]},{"name":"Endocrinology Unit, Padova University Hospital , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7310-5078","authenticated-orcid":false,"given":"Giulia","family":"Bovo","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]},{"name":"Endocrinology Unit, Padova University Hospital , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8999-0001","authenticated-orcid":false,"given":"Martina","family":"Montagnana","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]},{"name":"Laboratory Medicine Unit, Padova University Hospital , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-5727","authenticated-orcid":false,"given":"Mattia","family":"Barbot","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]},{"name":"Endocrinology Unit, Padova University Hospital , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-8716","authenticated-orcid":false,"given":"Filippo","family":"Ceccato","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, University of Padova , Padova 35128 ,","place":["Italy"]},{"name":"Endocrinology Unit, Padova University Hospital , Padova 35128 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"2","key":"2026091710323027600_dgag370-B1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"2026091710323027600_dgag370-B2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-024-00984-y","article-title":"Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches","volume":"20","author":"Prete","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2026091710323027600_dgag370-B3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/clinem\/dgae517","article-title":"Clinical and biochemical data for the diagnosis of endogenous hypercortisolism: the \u201cCushingomic\u201d approach","volume":"110","author":"Ceccato","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026091710323027600_dgag370-B4","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026091710323027600_dgag370-B5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2026091710323027600_dgag370-B6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40618-025-02758-3","article-title":"Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology","volume":"49","author":"Ceccato","year":"2026","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2026091710323027600_dgag370-B7","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1210\/jc.2007-0596","article-title":"Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series","volume":"92","author":"Pecori Giraldi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026091710323027600_dgag370-B8","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/clinem\/dgaa105","article-title":"Accuracy of laboratory tests for the diagnosis of Cushing syndrome","volume":"105","author":"Galm","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026091710323027600_dgag370-B9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/a-2299-5065","article-title":"Subtyping of Cushing's syndrome: a step ahead","volume":"132","author":"Tizianel","year":"2024","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2026091710323027600_dgag370-B10","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026091710323027600_dgag370-B11","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1210\/jc.2009-1500","article-title":"Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome","volume":"94","author":"Valassi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026091710323027600_dgag370-B12","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae002","article-title":"Overnight 1-mg DST serum cortisol in various stages of chronic kidney disease\u2014normative data and underlying mechanisms","volume":"8","author":"Garg","year":"2024","journal-title":"J Endocr Soc"},{"issue":"4","key":"2026091710323027600_dgag370-B13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ejendo\/lvaf053","article-title":"Impaired accuracy of the dexamethasone suppression test after bariatric surgery: implications for post-surgical cortisol interpretation","volume":"192","author":"Caster\u00e0s","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026091710323027600_dgag370-B14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40618-020-01197-6","article-title":"Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation","volume":"43","author":"Ceccato","year":"2020","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"2026091710323027600_dgag370-B15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eprac.2023.09.007","article-title":"Overnight 1-mg dexamethasone suppression test for screening Cushing syndrome and mild autonomous cortisol secretion (MACS): what happens when serum dexamethasone is below cutoff? How frequent is it?","volume":"29","author":"Farinelli","year":"2023","journal-title":"Endocr Pract"},{"issue":"6","key":"2026091710323027600_dgag370-B16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-17-0078","article-title":"Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test","volume":"176","author":"Ueland","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2026091710323027600_dgag370-B17","author":"Flockhart"},{"issue":"11","key":"2026091710323027600_dgag370-B18","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans: an update","volume":"94","author":"Hakkola","year":"2020","journal-title":"Arch Toxicol"},{"key":"2026091710323027600_dgag370-B19"},{"issue":"4","key":"2026091710323027600_dgag370-B20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2026091710323027600_dgag370-B21","doi-asserted-by":"crossref","unstructured":"Tizianel I, Antonelli G, Mondin A, et al \u00a0Clinical and pharmacological determinants of serum dexamethasone concentrations during 1-mg DST (repository). 2026. doi:10.25430\/researchdata.cab.unipd.it.00001906","DOI":"10.1210\/clinem\/dgag370"},{"issue":"5","key":"2026091710323027600_dgag370-B22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/cen.70065","article-title":"Value of the serum dexamethasone determination for the diagnosis of mild autonomous cortisol secretion","volume":"104","author":"Araujo-Castro","year":"2026","journal-title":"Clin Endocrinol"},{"issue":"9","key":"2026091710323027600_dgag370-B23","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0281","article-title":"Is evaluation of cortisol after dexamethasone suppression test enough? Analysis of steroid profile after dexamethasone suppression test using tandem mass spectrometry","volume":"14","author":"Brutvan","year":"2025","journal-title":"Endocr Connect"},{"issue":"3","key":"2026091710323027600_dgag370-B24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40262-025-01494-4","article-title":"Influence of ageing on the pharmacodynamics and pharmacokinetics of chronically administered medicines in geriatric patients: a review","volume":"64","author":"Ngcobo","year":"2025","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"2026091710323027600_dgag370-B25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-020-02392-4","article-title":"Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients","volume":"69","author":"Ceccato","year":"2020","journal-title":"Endocrine"},{"issue":"8","key":"2026091710323027600_dgag370-B26","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s00198-016-3574-y","article-title":"25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese","volume":"27","author":"Camozzi","year":"2016","journal-title":"Osteoporos Int"},{"issue":"2","key":"2026091710323027600_dgag370-B27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ejendo\/lvag132","article-title":"A new LC-MS\/MS assay for serum cortisol, cortisone, and dexamethasone: real-world utility for the interpretation of the 1-mg overnight dexamethasone suppression test","volume":"195","author":"Parasiliti-Caprino","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026091710323027600_dgag370-B28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/EC-12-0058","article-title":"Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease","volume":"2","author":"Raff","year":"2013","journal-title":"Endocr Connect"},{"issue":"6","key":"2026091710323027600_dgag370-B29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0004563218766566","article-title":"Development of a rapid liquid chromatography tandem mass spectrometry method for the quantitation of serum dexamethasone and its clinical verification","volume":"55","author":"Hawley","year":"2018","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"2026091710323027600_dgag370-B30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0004563219870834","article-title":"Retrospective analysis of repeated dexamethasone suppression tests \u2013 the added value of measuring dexamethasone","volume":"56","author":"De Graaf","year":"2019","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"2026091710323027600_dgag370-B31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jalm\/jfaa193","article-title":"Yield of serum dexamethasone measurement for reducing false-positive results of low-dose dexamethasone suppression testing","volume":"6","author":"Roper","year":"2021","journal-title":"J Appl Lab Med"},{"issue":"3","key":"2026091710323027600_dgag370-B32","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1210\/clinem\/dgab724","article-title":"Interpretation of abnormal dexamethasone suppression test is enhanced with use of synchronous free cortisol assessment","volume":"107","author":"Genere","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026091710323027600_dgag370-B33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/clinchem\/hvab056","article-title":"Method-specific cortisol and dexamethasone thresholds increase clinical specificity of the dexamethasone suppression test for Cushing syndrome","volume":"67","author":"Vogg","year":"2021","journal-title":"Clin Chem"},{"issue":"6","key":"2026091710323027600_dgag370-B34","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.eprac.2025.12.017","article-title":"Simultaneous liquid chromatography-tandem mass spectrometry quantification of cortisol and dexamethasone establishes a platform-specific dexamethasone lower limit and improves diagnostic specificity of the 1-mg overnight dexamethasone suppression test","volume":"32","author":"Gao","year":"2026","journal-title":"Endocr Pract"},{"issue":"6","key":"2026091710323027600_dgag370-B35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FTD.0b013e31815c16f5","article-title":"Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring","volume":"29","author":"Zhou","year":"2007","journal-title":"Ther Drug Monit"},{"issue":"2","key":"2026091710323027600_dgag370-B36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and duration of action of glucocorticoids","volume":"63","author":"Meikle","year":"1977","journal-title":"Am J Med"},{"issue":"7","key":"2026091710323027600_dgag370-B37","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1210\/jc.2002-021778","article-title":"Troglitazone induces CYP3A4 activity leading to falsely abnormal dexamethasone suppression test","volume":"88","author":"Dimaraki","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7486","key":"2026091710323027600_dgag370-B38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.330.7486.299","article-title":"Carbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome","volume":"330","author":"Ma","year":"2005","journal-title":"BMJ"},{"issue":"4","key":"2026091710323027600_dgag370-B39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-7824(90)90034-S","article-title":"Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone","volume":"41","author":"van der Vange","year":"1990","journal-title":"Contraception"},{"issue":"9","key":"2026091710323027600_dgag370-B40","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00228-023-03534-z","article-title":"Proton pump inhibitor use: systematic review of global trends and practices","volume":"79","author":"Shanika","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2026091710323027600_dgag370-B41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bcpt.13816","article-title":"Incidence in pharmacoepidemiology: a conceptual framework for incidence of a single substance or group of substances with statins as an example","volume":"132","author":"Hoffmann","year":"2023","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"2026091710323027600_dgag370-B42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40885-015-0029-2","article-title":"Clinical attributes, treatment, and control in hypertension (CATCH)\u2014a French and Italian longitudinal patient database study","volume":"21","author":"Wu","year":"2015","journal-title":"Clin Hypertens"},{"issue":"3","key":"2026091710323027600_dgag370-B43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11096-025-02078-9","article-title":"Antidepressant drug use in Europe: past consumption, prescribing patterns and forecast until 2030","volume":"48","author":"Bindel","year":"2026","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2026091710323027600_dgag370-B44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3956(02)00012-2","article-title":"Hypercortisolemia decreases dexamethasone half-life in rabbit","volume":"36","author":"Stokes","year":"2002","journal-title":"J Psychiatr Res"},{"issue":"9","key":"2026091710323027600_dgag370-B45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2213-8587(26)00098-7","article-title":"Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study","volume":"14","author":"Suntornlohanakul","year":"2026","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag370\/70992675\/dgag370.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag370\/70992675\/dgag370.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:32:43Z","timestamp":1789655563000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article\/doi\/10.1210\/clinem\/dgag370\/8787867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag370","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"dgag370"}}